New study provides insight into the mechanisms of blood clots in cancer patients

November 22, 2019

(Boston)--Researchers have identified a potential new signaling pathway that may help further the understanding of blood clot formation in cancer patients and ultimately help prevent this complication from occurring.

A pulmonary embolism generally occurs when a clot from the deep veins of the extremities also known as deep vein thrombosis (DVT) becomes dislodged and travels to the lungs. This event combined with the DVT is the second most common cause of non-cancer related death in patients with malignancy. Patients with cancer are at an increased risk of developing blood clots for reasons that had previously been unclear until now.

Researchers from Boston University School of Medicine (BUSM) performed a detailed analysis examining the levels of different molecules and break down products--known as metabolites in the blood as well as within blood clots from experimental tumor models. They discovered increased blood levels of two molecules called kynurenine and indoxyl sulfate, both of which are metabolites of the amino acid, tryptophan, often a dietary component. These high levels of kynurenine and indoxyl sulfate were also associated with increased blood clot size in an experimental model.

The study shows that by pharmacologically inhibiting the aryl hydrocarbon receptor (AHR) pathway, a known target of indoxyl sulfate and kynurenine, they could reduce blood clot size, suggesting that this may be a target for future drug development.

According to researchers, this study suggests that Kynurenine and indoxyl sulfate might be key culprits in generating clot formation in patients with cancer via AHR signaling. Moreover, they may provide exciting new opportunities for treating and preventing these known complications in the future. "The importance for the patient is two-fold," explained corresponding author Vipul Chitalia, MD, PhD, associate professor of medicine at BUSM. "First, these metabolites can be measured in the blood of patients with cancer and can potentially guide us in predicting risk of deep vein thrombosis. Also, the signaling pathway triggered by these metabolites can be potentially inhibited by compounds that can be developed in the future as a drug for this complication."

"In addition, dietary modifications could also be considered in such cases," adds coauthor Katya Ravid, DSc, professor of medicine and biochemistry at BUSM.
-end-
These findings appear online in the journal Blood.

Funding for this study was provided by National Institutes of Health, the National Heart, Lung, and Blood Institute, National Cancer Institute, Evans Faculty Merit award (V.C.C.), and the Department of Medicine of Boston University School of Medicine.

Boston University School of Medicine

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.